Journal of Clinical Investigation,
Год журнала:
2020,
Номер
130(5), С. 2286 - 2300
Опубликована: Апрель 5, 2020
Seizures
often
herald
the
clinical
appearance
of
gliomas
or
appear
at
later
stages.
Dissecting
their
precise
evolution
and
cellular
pathogenesis
in
brain
malignancies
could
inform
development
staged
therapies
for
these
highly
pharmaco-resistant
epilepsies.
Studies
immunodeficient
xenograft
models
have
identified
local
interneuron
loss
excess
glial
glutamate
release
as
chief
contributors
to
network
disinhibition,
but
how
hyperexcitability
peritumoral
microenvironment
evolves
an
immunocompetent
is
unclear.
We
generated
WT
mice
via
utero
deletion
key
tumor
suppressor
genes
serially
monitored
cortical
epileptogenesis
during
infiltration
with
vivo
electrophysiology
GCAMP7
calcium
imaging,
revealing
a
reproducible
progression
from
convulsive
seizures.
Long
before
seizures,
coincident
inhibitory
cells
protective
scaffolding,
gain
antiporter
xCT
expression,
reactive
astrocytosis,
we
detected
Iba1+
microglial
inflammation
that
intensified
extended
far
beyond
boundaries.
Hitherto
unrecognized
episodes
spreading
depolarization
arose
frequently
region
may
provide
mechanism
transient
neurological
deficits.
Early
blockade
activity
inhibited
genomic
reduction
host
excitability
by
deleting
MapT
suppressed
molecular
markers
Our
studies
confirmed
tumor–driven
pathobiology
revealed
early
late
components
tumor-related
genetically
tractable,
mouse
model
glioma,
allowing
complex
dissection
versus
pathogenic
seizure
mechanisms.
Gliomas
are
the
most
common
malignant
primary
brain
tumours
with
a
highly
immunosuppressive
tumour
microenvironment
(TME)
and
poor
prognosis.
Circular
RNAs
(circRNA),
newly
found
type
of
endogenous
noncoding
RNA,
characterized
by
high
stability,
abundance,
conservation,
have
been
shown
to
play
an
important
role
in
pathophysiological
processes
TME
remodelling
various
tumours.CircRNA
sequencing
analysis
was
performed
explore
circRNA
expression
profiles
normal
glioma
tissues.
The
biological
function
novel
circRNA,
namely,
circNEIL3,
development
confirmed
both
vitro
vivo.
Mechanistically,
RNA
pull-down,
mass
spectrum,
immunoprecipitation
(RIP),
luciferase
reporter,
co-immunoprecipitation
assays
were
conducted.We
identified
which
could
be
cyclized
EWS
RNA-binding
protein
1(EWSR1),
upregulated
tissues
correlate
positively
progression.
Functionally,
we
that
circNEIL3
promotes
tumorigenesis
carcinogenic
progression
stabilizes
IGF2BP3
(insulin-like
growth
factor
2
mRNA
binding
3)
protein,
known
oncogenic
preventing
HECTD4-mediated
ubiquitination.
Moreover,
overexpression
cells
drives
macrophage
infiltration
into
(TME).
Finally,
is
packaged
exosomes
hnRNPA2B1
transmitted
infiltrated
associated
macrophages
(TAMs),
enabling
them
acquire
properties
stabilizing
turn
promoting
progression.This
work
reveals
plays
nonnegligible
multifaceted
gliomagenesis,
tumour-promoting
phenotypes
polarization,
highlighting
potential
prognostic
biomarker
therapeutic
target
glioma.
Nature Immunology,
Год журнала:
2022,
Номер
23(6), С. 971 - 984
Опубликована: Май 27, 2022
Abstract
Glioblastoma
(GBM)
is
an
incurable
primary
malignant
brain
cancer
hallmarked
with
a
substantial
protumorigenic
immune
component.
Knowledge
of
the
GBM
microenvironment
during
tumor
evolution
and
standard
care
treatments
limited.
Using
single-cell
transcriptomics
flow
cytometry,
we
unveiled
large-scale
comprehensive
longitudinal
changes
in
cell
composition
throughout
progression
epidermal
growth
factor
receptor-driven
genetic
mouse
model.
We
identified
subsets
proinflammatory
microglia
developing
GBMs
anti-inflammatory
macrophages
myeloid-derived
suppressors
cells
end-stage
tumors,
that
parallels
breakdown
blood–brain
barrier
extensive
receptor
+
cells.
A
similar
relationship
was
found
between
patient
biopsies
low-grade
glioma
GBM.
Temozolomide
decreased
accumulation
suppressor
cells,
whereas
concomitant
temozolomide
irradiation
increased
intratumoral
GranzymeB
CD8
T
but
also
CD4
regulatory
These
results
provide
unbiased
cellular
landscape
its
evolutionary
progression.
Science Translational Medicine,
Год журнала:
2022,
Номер
14(656)
Опубликована: Авг. 3, 2022
Glioblastoma
multiforme
(GBM)
remains
incurable
despite
aggressive
implementation
of
multimodal
treatments
after
surgical
debulking.
Almost
all
patients
with
GBM
relapse
within
a
narrow
margin
around
the
initial
resected
lesion
due
to
postsurgery
residual
glioma
stem
cells
(GSCs).
Tracking
and
eradicating
GSCs
is
critical
for
preventing
postoperative
this
devastating
disease,
yet
effective
strategies
remain
elusive.
Here,
we
report
cavity-injectable
nanoporter-hydrogel
superstructure
that
creates
GSC-specific
chimeric
antigen
receptor
(CAR)
macrophages/microglia
(MΦs)
surrounding
cavity
prevent
relapse.
Specifically,
demonstrate
CAR
gene–laden
nanoporter
in
hydrogel
can
introduce
GSC-targeted
genes
into
MΦ
nuclei
intracavity
delivery
generate
CAR-MΦs
mouse
models
GBM.
These
were
able
seek
engulf
clear
by
stimulating
an
adaptive
antitumor
immune
response
tumor
microenvironment
prevented
inducing
long-term
immunity
mice.
In
orthotopic
patient–derived
glioblastoma
humanized
model,
combined
treatment
CD47
antibody
increased
frequency
positive
responding
suppressed
negative
regulating
cells,
conferring
robust
tumoricidal
postsurgical
inhibiting
Therefore,
our
work
establishes
locoregional
strategy
priming
cancer
cell–specific
broad
application
suffering
from
recurrent
malignancies.
Nature Cancer,
Год журнала:
2021,
Номер
2(7), С. 723 - 740
Опубликована: Май 24, 2021
Abstract
The
dynamics
and
phenotypes
of
intratumoral
myeloid
cells
during
tumor
progression
are
poorly
understood.
Here
we
define
cellular
states
in
gliomas
by
longitudinal
single-cell
profiling
demonstrate
their
strict
control
the
genotype:
isocitrate
dehydrogenase
(IDH)-mutant
tumors,
differentiation
infiltrating
is
blocked,
resulting
an
immature
phenotype.
In
late-stage
gliomas,
monocyte-derived
macrophages
drive
tolerogenic
alignment
microenvironment,
thus
preventing
T
cell
response.
We
IDH-dependent
education
to
be
causally
related
a
complex
re-orchestration
tryptophan
metabolism,
activation
aryl
hydrocarbon
receptor.
further
show
that
altered
metabolism
IDH-mutant
maintains
this
axis
bystander
pharmacological
inhibition
can
reverse
immunosuppression.
conclusion,
provide
evidence
glioma
genotype-dependent
network
resident
recruited
identify
as
target
for
immunotherapy
tumors.
Acta Neuropathologica Communications,
Год журнала:
2021,
Номер
9(1)
Опубликована: Март 25, 2021
Abstract
Glioblastoma
(GBM)
is
the
most
aggressive
and
deadliest
of
primary
brain
tumors,
characterized
by
malignant
growth,
invasion
into
parenchyma,
resistance
to
therapy.
GBM
a
heterogeneous
disease
high
degrees
both
inter-
intra-tumor
heterogeneity.
Another
layer
complexity
arises
from
unique
microenvironment
in
which
develops
grows.
The
consists
neoplastic
non-neoplastic
cells.
abundant
cells
are
those
innate
immune
system,
called
tumor-associated
macrophages
(TAMs).
TAMs
constitute
up
40%
tumor
mass
consist
brain-resident
microglia
bone
marrow-derived
myeloid
periphery.
Although
genetically
stable,
can
change
their
expression
profiles
based
upon
signals
that
they
receive
cells;
therefore,
heterogeneity
creates
TAMs.
By
interacting
with
other
microenvironment,
promote
progression.
Here,
we
review
origin,
heterogeneity,
functional
roles
In
addition,
discuss
prospects
therapeutically
targeting
alone
or
combination
standard
newly-emerging
therapies.
Cancer Discovery,
Год журнала:
2021,
Номер
11(9), С. 2248 - 2265
Опубликована: Апрель 9, 2021
Abstract
Chimeric
antigen
receptor
(CAR)
T
cells
mediate
potent
antigen-specific
antitumor
activity;
however,
their
indirect
effects
on
the
endogenous
immune
system
are
not
well
characterized.
Remarkably,
we
demonstrate
that
CAR
T-cell
treatment
of
mouse
syngeneic
glioblastoma
(GBM)
activates
intratumoral
myeloid
and
induces
memory
responses
coupled
with
feed-forward
propagation
responses.
IFNγ
production
by
responsiveness
host
critical
for
tumor
landscape
remodeling
to
promote
a
more
activated
less
suppressive
microenvironment.
The
clinical
relevance
these
observations
is
supported
studies
showing
human
IL13Rα2–CAR
activate
patient-derived
monocytes/macrophages
through
signaling
induce
generation
tumor-specific
in
responding
patient
GBM.
These
establish
therapy
has
potential
shape
microenvironment,
creating
context
permissible
eliciting
immunity.
Significance:
Our
findings
highlight
role
productive
We
can
resident
populations
immunity,
emphasizing
importance
innate
adaptive
immunity
solid
tumors.
This
article
highlighted
In
Issue
feature,
p.
2113